Beijing Tongrentang Co Ltd (600085) - Total Liabilities
Based on the latest financial reports, Beijing Tongrentang Co Ltd (600085) has total liabilities worth CN¥10.36 Billion CNY (≈ $1.52 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Beijing Tongrentang Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Beijing Tongrentang Co Ltd - Total Liabilities Trend (1994–2024)
This chart illustrates how Beijing Tongrentang Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Beijing Tongrentang Co Ltd (600085) asset resilience to evaluate the company's liquid asset resilience ratio.
Beijing Tongrentang Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Tongrentang Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
KBC Ancora
BR:KBCA
|
Belgium | €100.55 Million |
|
Granite Construction Incorporated
NYSE:GVA
|
USA | $2.81 Billion |
|
Bank of Suzhou
SHE:002966
|
China | CN¥723.62 Billion |
|
Core Scientific, Inc. Common Stock
NASDAQ:CORZ
|
USA | $3.31 Billion |
|
NewMarket Corporation
NYSE:NEU
|
USA | $1.71 Billion |
|
Versant Media Group, Inc. Class A Common Stock When-Issued
NASDAQ:VSNT
|
USA | $1.93 Billion |
|
United Bankshares Inc
NASDAQ:UBSI
|
USA | $28.16 Billion |
|
California Resources Corp
NYSE:CRC
|
USA | $3.73 Billion |
Liability Composition Analysis (1994–2024)
This chart breaks down Beijing Tongrentang Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Beijing Tongrentang Co Ltd (600085) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Tongrentang Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Tongrentang Co Ltd (1994–2024)
The table below shows the annual total liabilities of Beijing Tongrentang Co Ltd from 1994 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥10.30 Billion ≈ $1.51 Billion |
+4.72% |
| 2023-12-31 | CN¥9.83 Billion ≈ $1.44 Billion |
+14.46% |
| 2022-12-31 | CN¥8.59 Billion ≈ $1.26 Billion |
+2.26% |
| 2021-12-31 | CN¥8.40 Billion ≈ $1.23 Billion |
+33.53% |
| 2020-12-31 | CN¥6.29 Billion ≈ $920.59 Million |
+0.47% |
| 2019-12-31 | CN¥6.26 Billion ≈ $916.27 Million |
+5.27% |
| 2018-12-31 | CN¥5.95 Billion ≈ $870.42 Million |
+7.37% |
| 2017-12-31 | CN¥5.54 Billion ≈ $810.68 Million |
+11.21% |
| 2016-12-31 | CN¥4.98 Billion ≈ $728.98 Million |
+43.59% |
| 2015-12-31 | CN¥3.47 Billion ≈ $507.69 Million |
-19.32% |
| 2014-12-31 | CN¥4.30 Billion ≈ $629.26 Million |
+5.54% |
| 2013-12-31 | CN¥4.07 Billion ≈ $596.23 Million |
+0.27% |
| 2012-12-31 | CN¥4.06 Billion ≈ $594.62 Million |
+61.33% |
| 2011-12-31 | CN¥2.52 Billion ≈ $368.59 Million |
+98.64% |
| 2010-12-31 | CN¥1.27 Billion ≈ $185.55 Million |
+25.63% |
| 2009-12-31 | CN¥1.01 Billion ≈ $147.69 Million |
+15.74% |
| 2008-12-31 | CN¥872.09 Million ≈ $127.61 Million |
+7.09% |
| 2007-12-31 | CN¥814.33 Million ≈ $119.16 Million |
-5.57% |
| 2006-12-31 | CN¥862.40 Million ≈ $126.20 Million |
-5.82% |
| 2005-12-31 | CN¥915.65 Million ≈ $133.99 Million |
-4.31% |
| 2004-12-31 | CN¥956.91 Million ≈ $140.03 Million |
+28.12% |
| 2003-12-31 | CN¥746.90 Million ≈ $109.29 Million |
-7.44% |
| 2002-12-31 | CN¥806.96 Million ≈ $118.08 Million |
+14.58% |
| 2001-12-31 | CN¥704.27 Million ≈ $103.06 Million |
+28.41% |
| 2000-12-31 | CN¥548.45 Million ≈ $80.26 Million |
+26.29% |
| 1999-12-31 | CN¥434.28 Million ≈ $63.55 Million |
+2.28% |
| 1998-12-31 | CN¥424.58 Million ≈ $62.13 Million |
+7.90% |
| 1997-12-31 | CN¥393.50 Million ≈ $57.58 Million |
-7.07% |
| 1996-12-31 | CN¥423.41 Million ≈ $61.96 Million |
-4.43% |
| 1995-12-31 | CN¥443.04 Million ≈ $64.83 Million |
-3.33% |
| 1994-12-31 | CN¥458.28 Million ≈ $67.06 Million |
-- |
About Beijing Tongrentang Co Ltd
Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. It operates through the Company, Science Company, Commerce Company, and Others segments. The company offers various product dosage forms, such as pills, powders, alcoholic preparations, capsules, oral liquids, and dripping pills. Its products are used … Read more